Amesite Inc. (AMST) - Q1 2025 (Ended Sept 30, 2024) Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2024. Amesite Inc. is a technology company developing AI-driven solutions for higher education and healthcare, including the NurseMagic™ app. The company is classified as a smaller reporting company and an emerging growth company. As of November 14, 2024, there were 2,792,440 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2025 (Sept 30, 2024) | Q1 2024 (Sept 30, 2023) |
|---|---|---|
| Net Revenue | $11,250 | $63,333 |
| Net Loss | $(908,045) | $(890,693) |
| Loss Per Share (Basic/Diluted) | $(0.34) | $(0.35) |
| Cash and Cash Equivalents | $1,434,753 | $4,636,682 |
| Net Cash Used in Operating Activities | $(488,263) | $(658,779) |
| Total Assets | $3,236,110 | $3,314,177 |
| Accumulated Deficit | $(38,741,546) | $(34,321,012) |
Debt and Liquidity: The company has no long-term debt listed on the balance sheet. Current liabilities total $843,003, primarily consisting of accrued compensation ($688,075). The company holds $100,000 in restricted cash.
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased by approximately 82% to $11,250 from $63,333. Management attributes this to a strategic pivot away from large, cash-upfront deals that faced administrative barriers, toward a fee-per-course model for community colleges.
- Expense Reduction: Total operating expenses decreased to $938,594 from $1,013,323.
- Technology and Content Development: Dropped significantly to $139,658 from $333,434 due to headcount reductions and increased capitalization of software costs.
- Sales and Marketing: Decreased to $165,814 from $241,627 as marketing functions were moved in-house.
- General and Administrative: Increased to $633,122 from $438,262, driven by the recording of board compensation, partially offset by cost reductions.
- Capitalization: The company capitalized $148,000 in software development costs during the quarter, compared to $65,200 in the prior year.
- Equity Issuance: The company issued 250,000 shares of common stock valued at $720,000 to a consultant for services related to potential future financing. These were recorded as deferred issuance costs.
Outlook, Risks, and Management Commentary
Going Concern Warning: Management has concluded that there is substantial doubt about the company's ability to continue as a going concern. While management believes it may have sufficient cash for the next twelve months, this is not deemed probable. The company plans to raise additional funds through equity offerings, but success is not guaranteed.
Strategic Pivot: Amesite is focusing on AI-powered learning programs priced affordably for community colleges and the NurseMagic™ app for healthcare. The company aims to reduce cash burn while growing its customer base.
Risks:
- Reliance on a single customer for 100% of revenue in the current quarter.
- History of net losses and negative cash flows since inception.
- Dependence on third-party designers and partners.
- Need for additional financing to sustain operations.
Investor Verification Checklist
- Liquidity Runway: Verify the sufficiency of the $1.43 million cash balance against the current burn rate and the timeline for securing new financing.
- Revenue Concentration: Confirm the status of the single customer representing 100% of Q1 revenue and the stability of that contract.
- Deferred Issuance Costs: Monitor the $720,000 in deferred costs related to the consultant; these will be expensed if no financing transaction occurs by July 2025.
- Capitalization Policy: Review the criteria for capitalizing software costs to ensure they are not being used to artificially inflate assets or reduce current expenses.
- Accrued Liabilities: Assess the $688,075 in accrued compensation to understand potential cash outflow requirements.